A vaccinia replication system for producing recombinant hepatitis C virus

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Aim: To develop a cell culture system capable of producing high titer hepatitis C virus (HCV) stocks with recombinant vaccinia viruses as helpers. Methods: Two plasmids were used for the generation of recombinant HCV: one containing the full-length HCV cDNA cloned between T7 promoter and T7 terminator of pOCUS-T7 vector, and the other containing the HCV polyprotein open reading fame (ORF) direct1y linked to a vaccinia late promoter in PSC59. These two plasmids were co-transfected into BHK21 cells, which were then infected with vTF7-3 recombinant vaccinia helper viruses. Results: After 5 d of incubation, approximately 3.6×107 copies of HCV RNA were present per milliliter of cell culture supernatant, as detected by fluorescence quantitative RT-PCR (FQ-PCR). The yield of recombinant HCV using this cell system increased 100- to 1 000- fold compared to in vitro-transcribed HCV genomic RNA or selective subgenomic HCV RNA molecule method. Conclusion: This cell culture system is capable of producing high titer recombinant HCV. Copyright © 2004 by The WJG Press.

Cite

CITATION STYLE

APA

Wu, Y. S., Feng, Y., Dong, W. Q., Zhang, Y. M., & Li, M. (2004). A vaccinia replication system for producing recombinant hepatitis C virus. World Journal of Gastroenterology, 10(18), 2670–2674. https://doi.org/10.3748/wjg.v10.i18.2670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free